Clinical PET Head: Dr. Lutz Kracht
Imaging and characterization of disease-specific metabolic processes
Positron Emission Tomography (PET) is an imaging procedure by which metabolic processes in the body and brain can be visualized. Impaired metabolic processes are either the cause or consequence of many diseases. The main application of clinical PET is for the imaging and characterization of disease-specific metabolic processes.
Our work at the Max Planck Institute for neurological Research focusses on Oncology and Neurology.
Oncology: Improved diagnosis and treatment of malignant oncological disorders
One goal of the Clinical PET Group is to improve the diagnosis and treatment of malignant tumours with the specific aim of optimizing modern therapeutic procedures in Oncology and investigating tumour physiology through clinical studies. Our main focus here is on the development of techniques for monitoring the efficacy of new molecular approaches to treatment. For further information, please see list at the right-hand side.
In joint projects with our partners at the Department of Neurology at Cologne University, our main areas of investigation are:
For further information, please see list at the right-hand side.
Research topics in detail: